Biomarkers in Ovarian Disease
M. J. Birrer
IOS Press, 2007 - Medical - 120 pages
Contains a series of articles by experts in the ovarian cancer field, who present developments in the identification and understanding of biomarkers for this tumor. This title discusses hypotheses on the molecular development of ovarian cancer, SP markers of risk, and biomarkers and approaches for the early detection of ovarian cancer.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Mok J Kwong W R Welch G Samimi L Ozbun T Bonome
K K Wong and D Gershenson
G Samimi L Ozbun M E Johnson S C Mok and M J Birrer
Badgwell and R C Bast
Kohn N Azad C Annunziata A S Dhamoon and G Whiteley
Merritt and A K Sood
analysis angiogenesis antibodies antigen associated benign Biol biomarkers BRCA1 case-control study chemotherapy claudin claudin-3 Clin Cancer Res Clin Oncol clinical cohort colorectal cyclin cytokines diagnosis early stage ovarian elevated endothelial cells endothelial growth factor epithelial ovarian cancer gene expression profiles genetic grade Gynecol Oncol high-grade OSCs histologic hormone identified increased interleukin-8 intraepithelial T cells invasive IOS Press kinase levels LMP serous tumors LMP tumors low malignant potential low-grade OSCs markers metastasis metastatic microarray molecular mors mucinous carcinomas mucinous ovarian mucinous tumors mutations Oncogene ovarian cancer patients ovarian cancer risk ovarian carcinoma ovarian serous ovarian surface ovarian tumors ovary overall survival overexpression Pathol pathways patients with ovarian primary ovarian protein expression proteomic R.C. Bast receptor risk of ovarian role S.C. Mok samples screening sensitivity serous carcinomas serous tumors serum slide specificity stage ovarian cancer therapy tissue tumor suppressor gene vascular endothelial growth VEGF women